164 / 172
164
randomized controlled trial comparing methotrexate and gold
sodium thiomalate. Br J Rheumatol 1998;37:1220-6.
155. Das SK, Pareek A, Mathur DS, Wanchu A, Srivastava R,
Agarwal GG, et al. Efficacy and safety of hydroxychloroquine
sulphate in rheumatoid arthritis: a randomized, double-blind,
placebo controlled clinical trial--an Indian experience. Curr
Med Res Opin 2007; 23: 2227-34.
156.Tsakonas E, Fitzgerald AA, Fitzcharles MA, Cividino A,
Thorne JC, M'Seffar A, et al. Consequences of delayed therapy
with second-line agents in rheumatoid arthritis: a 3 year
followup on the hydroxychloroquine in early rheumatoid
arthritis (HERA) study. J Rheumatol 2000; 27: 623-9.
157.Furst DE, Lindsley H, Baethge B, Botstein GR, Caldwell J,
Dietz F, et al. Dose-loading with hydroxychloroquine
improves the rate of response in early, active rheumatoid
arthritis: a randomized, double-blind six-week trial with
eighteen-week extension. Arthritis Rheum 1999; 42: 357-65.
158.Clegg DO, Dietz F, Duffy J, Willkens RF, Hurd E, Germain
BF, et al. Safety and efficacy of hydroxychloroquine as
maintenance therapy for rheumatoid arthritis after
combination
therapy
with
methotrexate
and
hydroxychloroquine. J Rheumatol 1997; 24: 1896-902.
159.Trnavský K, Gatterová J, Lindusková M, Pelisková Z.
Combination therapy with hydroxychloroquine and
methotrexate in rheumatoid arthritis. Z Rheumatol 1993; 52:
292-6.
160.Porter DR, Capell HA, Hunter J. Combination therapy in
rheumatoid
arthritis--no
benefit
of
addition
of
hydroxychloroquine to patients with a suboptimal response to
intramuscular gold therapy. J Rheumatol 1993; 20: 645-9.
161.Keystone EC, Kavanaugh AF, Sharp JT, Tannenbaum H,
Hua Y, Teoh LS, et al. Radiographic, clinical, and functional
outcomes of treatment with adalimumab (a human anti-tumor
necrosis factor monoclonal antibody) in patients with active